Viyash Scientific enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


9,809	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
256	256	62.7	67.4	41.6
204	204	65.9	56.4	50.4
436	436	446	451	398
10,193	—	—	—	—
180	180	384	384	356
₹233.33	—	—	—	—

3,551	3,551	1,217	1,164	1,147
12.3%	12.3%	36.7%	38.8%	34.7%
0.04×	—	—	—	—

3.24×	—	—	—	—
17.16×	—	—	—	—
25.63×	—	—	—	—
54.16×	—	—	—	—
3,149	3,420	1,551	1,370	1,421
594	653	162	61.4	12.0
398	419	95.3	−0.1	−43.7
—	323	83.4	30.6	16.8
188	188	44.3	−0.2	−69.4
—	164	30.3	−21.0	−73.4
—	135	39.1	30.8	86.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VIYASH₹224.55

Viyash Scientific Ltd.

· Pharma & Health

₹ CrorePeersAARTIDRUGS YATHARTH THYROCARE SUPRIYA STAR SPARC SHILPAMED RUBICONMcap ₹9,809 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	9,809.5
- Cash, Equiv & ST Investments	41.6	67.4	62.7	255.8	255.8
+ Minority Interest	50.4	56.4	65.9	203.7	203.7
+ Total Debt	397.9	451.3	446.4	435.8	435.8
Enterprise Value	—	—	—	—	10,193.1
Net Debt (memo)	356.3	383.9	383.7	180.0	180.0
EV per Share	—	—	—	—	233.33

Total Capital	1,147.1	1,164.2	1,216.7	3,550.6	3,550.6
Total Debt/Total Capital	34.69	38.76	36.69	12.27	12.27
Total Debt/EV	—	—	—	—	0.04

EV/Sales	—	—	—	—	3.24
EV/EBITDA	—	—	—	—	17.16
EV/EBIT	—	—	—	—	25.63
EV/Free Cash Flow	—	—	—	—	54.16
Reference Items — Trailing FY Values
Sales	1,420.9	1,369.7	1,551.4	3,420.3	3,148.7
EBITDA	12.0	61.4	161.8	652.5	593.9
EBIT	-43.7	-0.1	95.3	418.9	397.8
Operating Cash Flow	16.8	30.6	83.4	322.9	—
Free Cash Flow	-69.4	-0.2	44.3	188.2	188.2
FCFF (free cash flow to the firm)	-73.4	-21.0	30.3	163.6	—
Capital Expenditure	86.2	30.8	39.1	134.7	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.